Skip to main content
  • nl
  • fr
  • en
  • de
Other official information and services: www.belgium.be
Logo of the Belgian Federal Authorities
Return to the FAMHP homepage
Your medicine and health products
  • About the FAMHP
  • Jobs
  • Publications
  • Press
  • Contact
  • Complaints
  • Webportal
  • Home
  • Human medicines
  • Veterinary medicines
  • Information for the public
  • Notification of adverse reactions or incidents
  • Home
  • Human medicines
  • Health Products
  • Medical devices and their accessories
  • Generalities

Generalities

Definitions

CE marking

Classification

Competences and role of authorities

Legislation regarding medical devices 

Presentations

 

 

 

 

 

 

 

 

 

 

 

Last updated on 08/02/2010

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

Search

News

11/12/2019
1 in 20 university students uses stimulant medicines in order to study better
10/12/2019
Diabetes medicines with metformin: traces or nitrosamine contamination detected
09/12/2019
Simplified composition of preparations for treating coughs and colds from 1 January 2020
04/12/2019
PharmaStatus: a new online application on the availability of medicines
All news

© 2016 - FAMHP

  • Site map
  • Disclaimer
  • Complaints
  • Contact